BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

713 related articles for article (PubMed ID: 33861727)

  • 1. Association between white matter hyperintensity load and grey matter atrophy in mild cognitive impairment is not unidirectional.
    Vipin A; Wong BYX; Kumar D; Low A; Ng KP; Kandiah N
    Aging (Albany NY); 2021 Apr; 13(8):10973-10988. PubMed ID: 33861727
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regional White Matter Hyperintensity Influences Grey Matter Atrophy in Mild Cognitive Impairment.
    Vipin A; Foo HJL; Lim JKW; Chander RJ; Yong TT; Ng ASL; Hameed S; Ting SKS; Zhou J; Kandiah N
    J Alzheimers Dis; 2018; 66(2):533-549. PubMed ID: 30320575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. APOE4 carrier status determines association between white matter disease and grey matter atrophy in early-stage dementia.
    Vipin A; Kumar D; Soo SA; Zailan FZ; Leow YJ; Koh CL; Ng ASL; Ng KP; Kandiah N
    Alzheimers Res Ther; 2023 Jun; 15(1):103. PubMed ID: 37270543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differentiation of Early Alzheimer's Disease, Mild Cognitive Impairment, and Cognitively Healthy Elderly Samples Using Multimodal Neuroimaging Indices.
    Joshi H; Bharath S; Balachandar R; Sadanand S; Vishwakarma HV; Aiyappan S; Saini J; Kumar KJ; John JP; Varghese M
    Brain Connect; 2019 Nov; 9(9):730-741. PubMed ID: 31389245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of Asymmetrical White Matter Hyperintensities and Apolipoprotein E4 on Cognitive Impairment.
    Low A; Ng KP; Chander RJ; Wong B; Kandiah N
    J Alzheimers Dis; 2019; 70(3):953-964. PubMed ID: 31306121
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between white matter hyperintensity and medial temporal atrophy at various stages of Alzheimer's disease.
    Kandiah N; Chander RJ; Ng A; Wen MC; Cenina AR; Assam PN
    Eur J Neurol; 2015 Jan; 22(1):150-5. PubMed ID: 25142829
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of white matter hyperintensities and gray matter volume with cognition in older individuals without cognitive impairment.
    Arvanitakis Z; Fleischman DA; Arfanakis K; Leurgans SE; Barnes LL; Bennett DA
    Brain Struct Funct; 2016 May; 221(4):2135-46. PubMed ID: 25833685
    [TBL] [Abstract][Full Text] [Related]  

  • 8. White matter hyperintensities are associated with grey matter atrophy and cognitive decline in Alzheimer's disease and frontotemporal dementia.
    Dadar M; Manera AL; Ducharme S; Collins DL
    Neurobiol Aging; 2022 Mar; 111():54-63. PubMed ID: 34968832
    [TBL] [Abstract][Full Text] [Related]  

  • 9. White matter hyperintensities mediate gray matter volume and processing speed relationship in cognitively unimpaired participants.
    Brugulat-Serrat A; Salvadó G; Operto G; Cacciaglia R; Sudre CH; Grau-Rivera O; Suárez-Calvet M; Falcon C; Sánchez-Benavides G; Gramunt N; Minguillon C; Fauria K; Barkhof F; Molinuevo JL; Gispert JD;
    Hum Brain Mapp; 2020 Apr; 41(5):1309-1322. PubMed ID: 31778002
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of white matter hyperintensities on cognition is mediated by cortical atrophy.
    Rizvi B; Narkhede A; Last BS; Budge M; Tosto G; Manly JJ; Schupf N; Mayeux R; Brickman AM
    Neurobiol Aging; 2018 Apr; 64():25-32. PubMed ID: 29328963
    [TBL] [Abstract][Full Text] [Related]  

  • 11. White matter hyperintensities and cognition across different Alzheimer's biomarker profiles.
    Lam S; Lipton RB; Harvey DJ; Zammit AR; Ezzati A;
    J Am Geriatr Soc; 2021 Jul; 69(7):1906-1915. PubMed ID: 33891712
    [TBL] [Abstract][Full Text] [Related]  

  • 12. White matter hyperintensities in progranulin-associated frontotemporal dementia: A longitudinal GENFI study.
    Sudre CH; Bocchetta M; Heller C; Convery R; Neason M; Moore KM; Cash DM; Thomas DL; Woollacott IOC; Foiani M; Heslegrave A; Shafei R; Greaves C; van Swieten J; Moreno F; Sanchez-Valle R; Borroni B; Laforce R; Masellis M; Tartaglia MC; Graff C; Galimberti D; Rowe JB; Finger E; Synofzik M; Vandenberghe R; de Mendonça A; Tagliavini F; Santana I; Ducharme S; Butler C; Gerhard A; Levin J; Danek A; Frisoni GB; Sorbi S; Otto M; Zetterberg H; Ourselin S; Cardoso MJ; Rohrer JD;
    Neuroimage Clin; 2019; 24():102077. PubMed ID: 31835286
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of White Matter Hyperintensity Progression with Cognitive Decline in Patients with Amnestic Mild Cognitive Impairment.
    Hirao K; Yamashita F; Tsugawa A; Haime R; Fukasawa R; Sato T; Kanetaka H; Umahara T; Sakurai H; Hanyu H; Shimizu S
    J Alzheimers Dis; 2021; 80(2):877-883. PubMed ID: 33579856
    [TBL] [Abstract][Full Text] [Related]  

  • 14. White matter hyperintensities and CSF Alzheimer disease biomarkers in preclinical Alzheimer disease.
    Soldan A; Pettigrew C; Zhu Y; Wang MC; Moghekar A; Gottesman RF; Singh B; Martinez O; Fletcher E; DeCarli C; Albert M;
    Neurology; 2020 Mar; 94(9):e950-e960. PubMed ID: 31888969
    [TBL] [Abstract][Full Text] [Related]  

  • 15. White Matter Hyperintensities in Mild Cognitive Impairment and Lower Risk of Cognitive Decline.
    Nolze-Charron G; Mouiha A; Duchesne S; Bocti C;
    J Alzheimers Dis; 2015; 46(4):855-62. PubMed ID: 26402625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cross-sectional and longitudinal associations between total and regional white matter hyperintensity volume and cognitive and motor function in Parkinson's disease.
    Pozorski V; Oh JM; Okonkwo O; Krislov S; Barzgari A; Theisen F; Sojkova J; Bendlin BB; Johnson SC; Gallagher CL
    Neuroimage Clin; 2019; 23():101870. PubMed ID: 31150958
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Topographical differences in white matter hyperintensity burden and cognition in aging, MCI, and AD.
    Kamal F; Morrison C; Maranzano J; Zeighami Y; Dadar M
    Geroscience; 2023 Feb; 45(1):1-16. PubMed ID: 36229760
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cortical and Subcortical Grey Matter Abnormalities in White Matter Hyperintensities and Subsequent Cognitive Impairment.
    Zhu W; Huang H; Yang S; Luo X; Zhu W; Xu S; Meng Q; Zuo C; Liu Y; Wang W;
    Neurosci Bull; 2021 Jun; 37(6):789-803. PubMed ID: 33826095
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential Effects of Confluent and Nonconfluent White Matter Hyperintensities on Functional Connectivity in Mild Cognitive Impairment.
    Kumar D; Vipin A; Wong B; Ng KP; Kandiah N
    Brain Connect; 2020 Dec; 10(10):547-554. PubMed ID: 33050714
    [No Abstract]   [Full Text] [Related]  

  • 20. Correlating Cognitive Decline with White Matter Lesion and Brain Atrophy Magnetic Resonance Imaging Measurements in Alzheimer's Disease.
    Bilello M; Doshi J; Nabavizadeh SA; Toledo JB; Erus G; Xie SX; Trojanowski JQ; Han X; Davatzikos C
    J Alzheimers Dis; 2015; 48(4):987-94. PubMed ID: 26402108
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.